CD4+ Cancer Research Results
CD4+, CD4+ T Cells: Click to Expand ⟱
| Source: |
| Type: |
CD4+ T cells are T lymphocytes that express T cell receptors (TCRs).
Majority of cancer immunotherapies focus on harnessing the anti-tumour CD8+ cytotoxic T cell response, the potential role of CD4+ ‘helper’ T cells has largely remained in the background.
multifaceted role of CD4+ T cells in the anti-tumour immune response.
CD4+ T cells play a critical role in developing and sustaining effective anti-tumour immunity, even in cancer immunotherapies specifically designed to activate a CD8+ CTL response.
|
MS, Multiple Sclerosis: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*CD4+↑, *MCP1↓, RANTES↓, *MIP‑1α↓, *Treg lymp↓, *IFN-γ↓, *IL17↓, *CXCc↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Immune & Inflammatory Signaling ⓘ
RANTES↓, 1,
Total Targets: 1
Pathway results for Effect on Normal Cells:
Migration ⓘ
Treg lymp↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, CXCc↓, 1, IFN-γ↓, 1, IL17↓, 1, MCP1↓, 1, MIP‑1α↓, 1,
Total Targets: 7
Scientific Paper Hit Count for: CD4+, CD4+ T Cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:62 Cells:% prod#:% Target#:544 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page